ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MLYS vs CMPS // ALTMAN Z-SCORE & DEBT/EQUITY

Mineralys Therapeutics Inc. (NASDAQ) VS. COMPASS Pathways Plc American Depository Shares (NASDAQ) • 15-METRIC TALLY: MLYS 4 — CMPS 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLYS VS. CMPS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MLYS CMPS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.40% -35.00% +6.60 MLYS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -7.58% -9.31% +1.73 MLYS /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 MLYS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.9 46.1 -9.20 CMPS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.61B $1.60B $5.1M MLYS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MLYS REV CMPS REV MLYS GROSS % CMPS GROSS % MLYS FCF CMPS FCF
FY 2025 $477.7M $501.3M — — -$142.4M -$157.2M
FY 2024 $538.7M $499.0M — — -$166.3M -$119.2M
FY 2023 $237.0M $383.4M — — -$81.2M -$97.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLYS // BETA —
CMPS // BETA —